Oct 6 (Reuters) - Ortho Regenerative Technologies Inc
ORTH.CD :
* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES SUCCESSFUL TYPE A MEETING WITH U.S. FDA ON CMC ELEMENTS FOR WHICH MORE INFORMATION WAS REQUIRED TO CLEAR IND CLINICAL HOLD
* ORTHO REGENERATIVE TECHNOLOGIES INC - AGREEMENT REACHED WITH FDA ON ELEMENTAL IMPURITY TESTING USING SELECTED STANDARD REFERENCE MATERIAL
* ORTHO REGENERATIVE TECHNOLOGIES INC - WILL PROVIDE PROTOCOL AND TESTING RESULTS DURING COMING WEEKS
* ORTHO REGENERATIVE TECHNOLOGIES INC - PATIENT ENROLMENT STILL EXPECTED TO START BY YEAR END
* ORTHO REGENERATIVE TECHNOLOGIES - FDA HAS CONFIRMED CLINICAL HOLD WILL BE CLEARED WITHIN 30 DAYS OF SUBMISSION OF PROTOCOL AND TESTING RESULTS
Source text for Eikon: ID:nCNWNg8pna Further company coverage: ORTH.CD
((Reuters.Briefs@thomsonreuters.com;))